[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate

C54H81N5O15 — CID 53327751

IUPAC[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](OC(=O)NNC(=O)c3ccc4nc(-c5ccc(C)cc5)[nH]c4c3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C54H81N5O15/c1-16-39-54(11,66)44(62)30(5)41(60)28(3)25-52(9,67-14)45(73-50-42(61)38(59(12)13)23-29(4)69-50)31(6)43(32(7)49(64)71-39)72-40-26-53(10,68-15)46(33(8)70-40)74-51(65)58-57-48(63)35-21-22-36-37(24-35)56-47(55-36)34-19-17-27(2)18-20-34/h17-22,24,28-33,38-40,42-46,50,61-62,66H,16,23,25-26H2,1-15H3,(H,55,56)(H,57,63)(H,58,65)/t28-,29-,30+,31+,32-,33+,38+,39-,40+,42-,43+,44-,45-,46+,50+,52-,53-,54-/m1/s1
InChIKeyUSUJHJKMCIPGLJ-DIRYUZEZSA-N
MW1040.26 g/mol
LogP5.37
Rot. Bonds11

About [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate

[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate (PubChem CID 53327751) has the molecular formula C54H81N5O15 and a molecular weight of 1040.26 g/mol. Its IUPAC name is [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate.

Molecular Properties

Compound Name[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate
PubChem CID53327751
Molecular FormulaC54H81N5O15
Molecular Weight1040.26 g/mol
Exact Mass1039.57
IUPAC Name[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](OC(=O)NNC(=O)c3ccc4nc(-c5ccc(C)cc5)[nH]c4c3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C54H81N5O15/c1-16-39-54(11,66)44(62)30(5)41(60)28(3)25-52(9,67-14)45(73-50-42(61)38(59(12)13)23-29(4)69-50)31(6)43(32(7)49(64)71-39)72-40-26-53(10,68-15)46(33(8)70-40)74-51(65)58-57-48(63)35-21-22-36-37(24-35)56-47(55-36)34-19-17-27(2)18-20-34/h17-22,24,28-33,38-40,42-46,50,61-62,66H,16,23,25-26H2,1-15H3,(H,55,56)(H,57,63)(H,58,65)/t28-,29-,30+,31+,32-,33+,38+,39-,40+,42-,43+,44-,45-,46+,50+,52-,53-,54-/m1/s1
InChIKeyUSUJHJKMCIPGLJ-DIRYUZEZSA-N
XLogP5.37
TPSA258.79 Ų
H-Bond Donors6
H-Bond Acceptors17
Rotatable Bonds11
Heavy Atoms74
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001040.26
LogP ≤ 55.37
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate?
The IUPAC name of [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate (CID 53327751) is [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate.
What is the SMILES notation for [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate?
The canonical SMILES for [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate is CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](OC(=O)NNC(=O)c3ccc4nc(-c5ccc(C)cc5)[nH]c4c3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate?
The InChIKey is USUJHJKMCIPGLJ-DIRYUZEZSA-N. The full InChI is InChI=1S/C54H81N5O15/c1-16-39-54(11,66)44(62)30(5)41(60)28(3)25-52(9,67-14)45(73-50-42(61)38(59(12)13)23-29(4)69-50)31(6)43(32(7)49(64)71-39)72-40-26-53(10,68-15)46(33(8)70-40)74-51(65)58-57-48(63)35-21-22-36-37(24-35)56-47(55-36)34-19-17-27(2)18-20-34/h17-22,24,28-33,38-40,42-46,50,61-62,66H,16,23,25-26H2,1-15H3,(H,55,56)(H,57,63)(H,58,65)/t28-,29-,30+,31+,32-,33+,38+,39-,40+,42-,43+,44-,45-,46+,50+,52-,53-,54-/m1/s1.
What are the key properties of [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate?
[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate has a molecular weight of 1040.26 g/mol, XLogP of 5.37, 11 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3S,4R,6R)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] N-[[2-(4-methylphenyl)-3H-benzimidazole-5-carbonyl]amino]carbamate is sourced from PubChem (CID 53327751), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).